Dec 11, 20201 min read

MedCity Invest Precision Medicine: Clinical Trial Design Trends

Last month, Medaptive Health CEO Clay Williams joined Peyton Howell of Parexel and Viraj Narayanan of COTA on a panel on Clinical Trial Design Trends as part of the MedCity Invest Precision Medicine event. They discussed how changes driven by the pandemic can lead to sustained innovation in clinical trials.

Check out the replay at https://lnkd.in/e3BFVxR

Recent Posts

See All

Meet Jay Goss, General Partner at Wavemaker THREE-SIXTY HEALTH

By: Steven Loeb Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times...

MATTERWORKS ANNOUNCES UPDATES TO ITS BOARD OF DIRECTORS

Matterworks, Inc., developers of the world's most powerful metabolomics platform, which accelerates the discovery, development, and...

Luna Teams Up with UCI Health to Expand Access to Care with In-Home Outpatient Physical Therapy

Luna, the leading provider of in-home physical therapy, has teamed up with UCI Health, to expand access to patient care by providing...

MedCity Invest Precision Medicine: Clinical Trial Design Trends

Recent Posts

Comments